IS1963B - Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun - Google Patents
Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkunInfo
- Publication number
- IS1963B IS1963B IS4537A IS4537A IS1963B IS 1963 B IS1963 B IS 1963B IS 4537 A IS4537 A IS 4537A IS 4537 A IS4537 A IS 4537A IS 1963 B IS1963 B IS 1963B
- Authority
- IS
- Iceland
- Prior art keywords
- extract
- cartilage
- homogenate
- shark cartilage
- extracts
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 7
- 210000000845 cartilage Anatomy 0.000 title abstract 5
- 241000251730 Chondrichthyes Species 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000284 extract Substances 0.000 abstract 8
- 239000007788 liquid Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 230000001772 anti-angiogenic effect Effects 0.000 abstract 1
- 230000000791 anti-collagenolytic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 229940007115 shark cartilage extract Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Gerontology & Geriatric Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/384,555 US5618925A (en) | 1994-04-28 | 1995-02-03 | Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| PCT/CA1995/000617 WO1996023512A1 (en) | 1995-02-03 | 1995-10-30 | Extracts of shark cartilage, process of production and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS4537A IS4537A (is) | 1997-08-01 |
| IS1963B true IS1963B (is) | 2004-12-15 |
Family
ID=23517788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4537A IS1963B (is) | 1995-02-03 | 1997-08-01 | Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0806960B1 (is) |
| JP (3) | JPH11502514A (is) |
| KR (1) | KR100347880B1 (is) |
| CN (1) | CN1138550C (is) |
| AT (1) | ATE230272T1 (is) |
| AU (1) | AU717978B2 (is) |
| BG (1) | BG63801B1 (is) |
| BR (1) | BR9510540A (is) |
| CA (1) | CA2212010C (is) |
| CZ (1) | CZ292627B6 (is) |
| DE (1) | DE69529300T2 (is) |
| DK (1) | DK0806960T3 (is) |
| ES (1) | ES2188672T3 (is) |
| FI (1) | FI117376B (is) |
| HU (1) | HU222088B1 (is) |
| IS (1) | IS1963B (is) |
| MX (1) | MX9705894A (is) |
| NO (1) | NO318950B1 (is) |
| NZ (1) | NZ294553A (is) |
| PL (1) | PL188137B1 (is) |
| RO (1) | RO117590B1 (is) |
| RU (1) | RU2157695C2 (is) |
| WO (1) | WO1996023512A1 (is) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6380366B1 (en) | 1994-04-28 | 2002-04-30 | Les Laboratoires Aeterna Inc. | Shark cartilage extract:process of making, methods of using and compositions thereof |
| US6025334A (en) * | 1994-04-28 | 2000-02-15 | Les Laboratoires Aeterna Inc. | Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof |
| AU724654B2 (en) * | 1995-04-21 | 2000-09-28 | Aeterna Zentaris Inc. | Extracts of shark cartilage |
| AU6639898A (en) | 1997-02-20 | 1998-09-09 | Industrial Research Limited | Angiogenesis inhibitors and activators from shark cartilage |
| ES2200316T3 (es) * | 1997-03-11 | 2004-03-01 | Les Laboratoires Aeterna Inc. | Composiciones para tratar tumores que contienen extractos de cartilago de tiburon y agentes antineoplasticos. |
| CN1288165C (zh) * | 1997-07-11 | 2006-12-06 | Cv技术公司 | 用于治疗与phf过多或细胞内钙过多相关疾病的来自鲨软骨的制剂 |
| AUPO920597A0 (en) * | 1997-09-16 | 1997-10-09 | Micronized Foods Pty Ltd | Pharmaceutical and/or therapeutic composition or preparation comprising shark cartilage and emu oil |
| US20020009501A1 (en) * | 1998-07-23 | 2002-01-24 | Eric Dupont | Preparation of cartilage extracts using organic solvents |
| US6168807B1 (en) | 1998-07-23 | 2001-01-02 | Les Laboratoires Aeterna Inc. | Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
| CN1064690C (zh) * | 1998-09-10 | 2001-04-18 | 中国人民解放军海军医学研究所 | 鲨鱼软骨血管生成抑制因子及其分离纯化方法 |
| RU2161002C1 (ru) * | 1999-07-30 | 2000-12-27 | Государственное унитарное предприятие Тихоокеанский научно-исследовательский рыбохозяйственный центр | Пищевой общеукрепляющий лечебно-профилактический продукт из хрящевой ткани акул и способ его получения |
| US6248341B1 (en) * | 2000-01-14 | 2001-06-19 | Color Access, Inc. | Method of treating topical angiogenesis-related disorders |
| ATE536858T1 (de) | 2000-04-18 | 2011-12-15 | Medestea Int Spa | Zubereitung auf basis natürlicher extrakte zur vorbeugung und behandlung von hautfalten |
| AU1649802A (en) * | 2000-12-20 | 2002-07-01 | Ind Res Ltd | Shark meat extract |
| JPWO2004083257A1 (ja) * | 2003-03-20 | 2006-06-22 | ホソカワミクロン株式会社 | 軟骨魚類から単離されたプロテオグリカンおよびその製造方法 |
| ES2223291B1 (es) * | 2003-08-06 | 2006-03-16 | Bioiberica, S.A. | Nuevo uso terapeutico de condroitin sulfato. |
| US7205006B2 (en) * | 2003-09-25 | 2007-04-17 | Prime Pharmaceutical Corporation | Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
| CN100377741C (zh) * | 2004-02-23 | 2008-04-02 | 江卫世 | 注射用复方骨肽及其制备工艺 |
| RU2250774C1 (ru) * | 2004-04-29 | 2005-04-27 | Научно-исследовательский институт медико-биологических проблем Владикавказского научного центра РАН и Правительства РСО-Алания (НИИ МБП ВНЦ РАН) | Способ оптимизации лечения хронического простатита |
| US20070248930A1 (en) | 2005-02-17 | 2007-10-25 | Biolux Research Ltd. | Light therapy apparatus and methods |
| WO2012075584A1 (en) | 2010-12-08 | 2012-06-14 | Biolux Research Limited | Methods and apparatuses useful for regulating bone remodeling or tooth movement using light therapy, a functional appliance, and/or vitamin d |
| BR112014013561B1 (pt) * | 2011-12-04 | 2019-04-24 | David L. Liu | Composição farmacêutica útil para o tratamento de um câncer, tumor maligno, tumor benigno e doenças não-malignas |
| RU2489906C1 (ru) * | 2012-04-18 | 2013-08-20 | Тамара Ивановна Николаева | Биологически активная добавка к пище на основе денатурированного коллагена |
| US20130287859A1 (en) * | 2012-04-26 | 2013-10-31 | Lescarden Inc. | Method for treating prupritus with cartilage extract |
| DE102012023927A1 (de) * | 2012-12-06 | 2014-06-12 | Heinrich Huber | Heilsalbe gegen Psoriasis, auch als Wundsalbe verwendbar; 50 ml ohne Konservierung |
| CN105682603A (zh) | 2013-10-22 | 2016-06-15 | 碧奥鲁克斯研究有限公司 | 口腔内光疗法装置以及使用它们的方法 |
| CN106492065A (zh) * | 2016-10-20 | 2017-03-15 | 王凯茜 | 一种治疗风湿热的中药 |
| KR102369902B1 (ko) * | 2021-04-23 | 2022-03-02 | 이수한 | 전 처리된 캐비아가 함유된 철갑상어 진액 및 그 제조 방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4822607A (en) * | 1976-10-29 | 1989-04-18 | Lescarden Ltd. | Anti-tumor agent and method |
| US4473551A (en) * | 1982-08-23 | 1984-09-25 | Faxon Pharmaceuticals, Inc. | Anti-inflammatory composition |
| US4486414A (en) * | 1983-03-21 | 1984-12-04 | Arizona Board Of Reagents | Dolastatins A and B cell growth inhibitory substances |
| US5075112A (en) * | 1990-02-12 | 1991-12-24 | Cartilage Technologies Inc. | Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage |
| IT1244879B (it) * | 1990-12-11 | 1994-09-12 | Alberto Bartorelli | Estratti da tessuti animali, utili in terapia e in diagnostica. |
| RU2019180C1 (ru) * | 1993-01-12 | 1994-09-15 | Яков Давидович Безман | Средство для лечения подкожной фибросаркомы и способ его получения |
| RU2019173C1 (ru) * | 1993-01-12 | 1994-09-15 | Яков Давидович Безман | Способ лечения подкожной фибросаркомы |
| US5618925A (en) * | 1994-04-28 | 1997-04-08 | Les Laboratories Aeterna Inc. | Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
-
1995
- 1995-10-30 AU AU37388/95A patent/AU717978B2/en not_active Ceased
- 1995-10-30 EP EP95935309A patent/EP0806960B1/en not_active Expired - Lifetime
- 1995-10-30 JP JP8523128A patent/JPH11502514A/ja active Pending
- 1995-10-30 CA CA002212010A patent/CA2212010C/en not_active Expired - Fee Related
- 1995-10-30 NZ NZ294553A patent/NZ294553A/xx unknown
- 1995-10-30 WO PCT/CA1995/000617 patent/WO1996023512A1/en not_active Ceased
- 1995-10-30 HU HU9800065A patent/HU222088B1/hu not_active IP Right Cessation
- 1995-10-30 ES ES95935309T patent/ES2188672T3/es not_active Expired - Lifetime
- 1995-10-30 RO RO97-01452A patent/RO117590B1/ro unknown
- 1995-10-30 PL PL95321678A patent/PL188137B1/pl not_active IP Right Cessation
- 1995-10-30 CN CNB951977598A patent/CN1138550C/zh not_active Expired - Fee Related
- 1995-10-30 AT AT95935309T patent/ATE230272T1/de not_active IP Right Cessation
- 1995-10-30 CZ CZ19972452A patent/CZ292627B6/cs not_active IP Right Cessation
- 1995-10-30 DE DE69529300T patent/DE69529300T2/de not_active Expired - Fee Related
- 1995-10-30 DK DK95935309T patent/DK0806960T3/da active
- 1995-10-30 RU RU97114752/14A patent/RU2157695C2/ru not_active IP Right Cessation
- 1995-10-30 KR KR1019970705335A patent/KR100347880B1/ko not_active Expired - Fee Related
- 1995-10-30 BR BR9510540A patent/BR9510540A/pt not_active Application Discontinuation
-
1997
- 1997-08-01 MX MX9705894A patent/MX9705894A/es not_active IP Right Cessation
- 1997-08-01 IS IS4537A patent/IS1963B/is unknown
- 1997-08-01 NO NO19973564A patent/NO318950B1/no unknown
- 1997-08-01 FI FI973195A patent/FI117376B/fi not_active IP Right Cessation
- 1997-09-01 BG BG101870A patent/BG63801B1/bg unknown
-
2003
- 2003-02-05 JP JP2003028771A patent/JP2003246742A/ja active Pending
-
2006
- 2006-07-31 JP JP2006208897A patent/JP2006290904A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2017B (is) | Seyði úr hákarlabrjóski | |
| IS4537A (is) | Seyði úr hákarlabrjóski, aðferð við framleiðslu þess og notkun | |
| FI964327A0 (fi) | Hainrusto uutteet joilla on antiangiogeenista aktiivisuutta ja vaikutusta kasvainregressioon; menetelmä niiden valmistamiseksi | |
| MX9306960A (es) | Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion. | |
| ITPD920071A1 (it) | Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo | |
| EP0759029A4 (en) | MODIFIED GROWTH FACTORS CONTAINED IN MILK | |
| ATE151774T1 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen | |
| EP0635009A1 (en) | DERIVATIVES OF 2,3-DIHYDRO-2,2,4,6,7-PENTAALKYL-5-BENZOFURANES. | |
| BR9307592A (pt) | Método e aparelhagem para desidratar produtos biológicos e produtos biológicos desidratados | |
| ATE128354T1 (de) | Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen. | |
| TH18293A (th) | ผลิตภัณฑ์เครื่องสำอาง |